Regulation of cofilin phosphorylation in glomerular podocytes by testis specific kinase 1 (TESK1)

Area of Science:

• Nephrology
• Cell Biology
• Molecular Biology

Background:

• Constitutively active Rho A (V14Rho) in podocytes causes albuminuria and foot process effacement.
• Rho kinase (ROK) is a downstream effector of Rho A, but its inhibition did not prevent V14Rho-induced kidney damage.
• Sustained cofilin 1 (CFL1) phosphorylation is linked to nephrotic diseases.

Purpose of the Study:

• To investigate the role of testis-specific kinase 1 (TESK1) in podocyte cytoskeletal regulation and glomerular filtration barrier integrity.
• To determine if TESK1 mediates CFL1 phosphorylation in podocytes, independent of ROK.
• To explore the therapeutic potential of targeting TESK1 in kidney diseases.

Main Methods:

• In vivo studies using V14Rho mice and ROK inhibitor Y27632.
• In vitro studies using cultured podocytes and TESK1 knockout (KO) podocytes.
• Analysis of phospho-cofilin 1 (pCFL1) levels and podocyte motility.

Main Results:

• ROK inhibition with Y27632 did not reduce pCFL1 levels or albuminuria in V14Rho mice.
• Y27632 had minimal effect on pCFL1 in wild-type cultured podocytes but significantly reduced it in TESK1 KO podocytes.
• ROK inhibition enhanced podocyte motility, but this effect was abolished in TESK1 KO podocytes.

Conclusions:

• TESK1, not ROK, is the primary kinase responsible for CFL1 phosphorylation in podocytes.
• TESK1 plays a crucial role in regulating podocyte cytoskeletal dynamics.
• TESK1 is a potential therapeutic target for preserving glomerular filtration barrier integrity in kidney diseases.